Page last updated: 2024-11-03

opc 12759 and Vitiligo

opc 12759 has been researched along with Vitiligo in 1 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feily, A1
Rasaii, S1
Nilforoushzadeh, MA1

Other Studies

1 other study available for opc 12759 and Vitiligo

ArticleYear
Rebamipide as a novel addition to the antivitiligo ordnance.
    International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:12

    Topics: Alanine; Antioxidants; Cytokines; Humans; Oxidative Stress; Quinolones; Vitiligo

2015